Biogen trumpeted new Phase 2 lupus data on Saturday for a program it hopes will become a pillar of its immunology pipeline.
The drug litifilimab improved patients’ skin lesions after 24 weeks, with 14.7% reaching …
Merck’s drug enlicitide beat a handful of commonly used cholesterol-lowering drugs in a comparator trial, inching it closer to becoming the first oral PCSK9 inhibitor.
During this year’s American Academy of Dermatology annual meeting in Denver, companies like Sanofi, Biogen and Tanabe Pharma presented data for their respective candidates. But
Attempts by the White House to curry industry support for legislation that would codify last year’s voluntary drug pricing deals are being ignored by some
Nearly all of Incheon-headquartered Samsung Biologics’ union members have supported plans to strike over wage negotiations, after an internal employee data leak in November. The
Two decades ago, when I was a baby-faced Capitol Hill reporter, Texas Republican Michael Burgess was a relatively new member of Congress, swept in with
Biogen trumpeted new Phase 2 lupus data on Saturday for a program it hopes will become a pillar of its immunology pipeline.
The drug litifilimab improved patients’ skin lesions after 24 weeks, with 14.7% reaching …